There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

With Carl Zeiss Meditech AG, I believe the company's troubles are ... CZMWF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own ...

The broader Asia-Pacific region was also a weak spot, with organic growth in ophthalmology devices down 4.5% for the year, ...

when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a lot of attention from a... Carl Zeiss Meditec AG announced today that, after securing all ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...

EQS-News: Carl Zeiss Meditec AG / Key word (s): Annual Report/Annual Results Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved 11.12.2024 ...

View Carl Zeiss Meditec AG (CZMWY) current and estimated P/E ratio data provided by Seeking Alpha.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...